These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27863836)

  • 1. Looking at flubromazolam metabolism from four different angles: Metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry.
    Wohlfarth A; Vikingsson S; Roman M; Andersson M; Kugelberg FC; Green H; Kronstrand R
    Forensic Sci Int; 2017 May; 274():55-63. PubMed ID: 27863836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples.
    Noble C; Mardal M; Bjerre Holm N; Stybe Johansen S; Linnet K
    Drug Test Anal; 2017 Aug; 9(8):1182-1191. PubMed ID: 27935260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
    Pettersson Bergstrand M; Meyer MR; Beck O; Helander A
    Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
    Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
    Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine.
    Huppertz LM; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):206-211. PubMed ID: 28378533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam.
    Wagmann L; Manier SK; Felske C; Gampfer TM; Richter MJ; Eckstein N; Meyer MR
    J Anal Toxicol; 2021 Nov; 45(9):1014-1027. PubMed ID: 33048135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolite Profiling of Ortho-, Meta- and Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry.
    Gundersen POM; Åstrand A; Gréen H; Josefsson M; Spigset O; Vikingsson S
    J Anal Toxicol; 2020 Mar; 44(2):140-148. PubMed ID: 31788682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
    Grafinger KE; Hädener M; König S; Weinmann W
    Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
    El Balkhi S; Chaslot M; Picard N; Dulaurent S; Delage M; Mathieu O; Saint-Marcoux F
    Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism.
    Kintz P; Richeval C; Jamey C; Ameline A; Allorge D; Gaulier JM; Raul JS
    Drug Test Anal; 2017 Jul; 9(7):1026-1033. PubMed ID: 27671107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
    Steuer AE; Williner E; Staeheli SN; Kraemer T
    Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.
    Gandhi AS; Wohlfarth A; Zhu M; Pang S; Castaneto M; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Mar; 7(3):187-98. PubMed ID: 24827428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Mortelé O; Vervliet P; Gys C; Degreef M; Cuykx M; Maudens K; Covaci A; van Nuijs ALN; Lai FY
    J Pharm Biomed Anal; 2018 May; 153():158-167. PubMed ID: 29494888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
    Carlier J; Diao X; Huestis MA
    J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples.
    Vikingsson S; Wohlfarth A; Andersson M; Gréen H; Roman M; Josefsson M; Kugelberg FC; Kronstrand R
    AAPS J; 2017 May; 19(3):736-742. PubMed ID: 28091881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the in vitro and in vivo metabolism of 4-HO-MET.
    Bruni PS; Grafinger KE; Nussbaumer S; König S; Schürch S; Weinmann W
    Forensic Sci Int; 2018 Sep; 290():103-110. PubMed ID: 30015274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
    Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
    Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
    Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
    Pettersson Bergstrand M; Richter LHJ; Maurer HH; Wagmann L; Meyer MR
    Drug Test Anal; 2019 Jan; 11(1):45-50. PubMed ID: 29996009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.